Biomarin Pharmaceutical Inc (BMRN)

Inventory turnover

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cost of revenue	US$ in thousands	580,235	532,062	483,669	470,515	524,272
Inventory	US$ in thousands	1,232,650	1,107,180	894,083	776,669	698,548
Inventory turnover		0.47	0.48	0.54	0.61	0.75

December 31, 2024 calculation

Inventory turnover = Cost of revenue ÷ Inventory
= $580,235K ÷ $1,232,650K
= 0.47

Biomarin Pharmaceutical Inc's inventory turnover has been gradually decreasing over the years, indicating a decline in the efficiency of managing its inventory levels. The company's inventory turnover ratio was 0.75 in December 2020, dropping to 0.61 in December 2021, and further decreasing to 0.54 in December 2022. By December 2023, the ratio fell to 0.48, and in December 2024, it reached its lowest point at 0.47. This trend suggests that Biomarin Pharmaceutical Inc may be experiencing challenges in selling its inventory efficiently or effectively controlling its production levels. Further analysis and proactive inventory management strategies may be necessary to address this declining trend in inventory turnover.